Abstract:Photodynamic therapy (PDT), characterized by high treatment efficiency, absence of drug resistance, minimal trauma, and few side effects, has gradually emerged as a novel and alternative clinical approach compared to traditional surgical resection, chemotherapy and radiation. Whereas, considering the limited diffusion distance and short lifespan of reactive oxygen species (ROS), as well as the hypoxic tumor microenvironment, it is crucial to design photosensitizers (PSs) with suborganelle specific targeting ability and low-oxygen dependence for accurate and highly efficient photodynamic therapy. In this study, we have meticulously designed three PSs, namely CIH, CIBr, and CIPh, based on molecular engineering. Theoretical calculation demonstrate that the three compounds possess good molecular planarity with calculated S1-T1 energy gaps (ΔES1-T1) of 1.04 eV for CIH, 0.92 eV for CIBr, and 0.84 eV for CIPh respectively. Notably, CIPh showcases remarkable dual subcellular targeting capability towards lipid droplets (LDs) and mitochondria owing to the synergistic effect of lipophilicity derived from coumarin's inherent properties combined with electropositivity conferred by indole salt cations. Furthermore, CIPh demonstrates exclusive release of singlet oxygen (1O2)and highly efficient superoxide anion free radicals(O2⦁-) upon light irradiation supported by its smallest S1-T1 energy gap (ΔES1-T1 = 0.84 eV). This leads to compromised integrity of LDs along with mitochondrial membrane potential, resulting in profound apoptosis induction in HepG2 cells. This successful example of molecular engineering guided by density functional theory (DFT) provides valuable experience for the development of more effective PSs with superior dual targeting specificity. It also provides a new idea for the development of advanced PSs with efficient and accurate ROS generation ability towards fluorescence imaging-guided hypoxic tumor therapy.

Molecular engineering to achieve AIE-active photosensitizer with NIR emission and rapid ROS generation efficiency

Molecular Engineering to Achieve AIE-active Photosensitizers with NIR Emission and Rapid ROS Generation Efficiency

Molecular engineering to enhance the reactive oxygen species generation of AIEgens and exploration of their versatile applications

Molecular Engineering of Efficient Singlet Oxygen Generators with Near‐Infrared AIE Features for Mitochondrial Targeted Photodynamic Therapy

Precise Molecular Engineering of Photosensitizers with Aggregation‐Induced Emission over 800 Nm for Photodynamic Therapy

Donor-Acceptor Modulating of Ionic AIE Photosensitizers for Enhanced ROS Generation and NIR-II Emission

Near-infrared AIEgens with high singlet-oxygen yields for mitochondria-specific imaging and antitumor photodynamic therapy

Molecular engineering of tetraphenylethene/thiophene-based donor/ π -bridge units to enhance the AIE effect and boost the oxygen-independent type-I ROS generation

A feasible molecular engineering for bright Π-conjugation free radical photosensitizers with aggregation-induced emission

Molecular Engineering to Boost AIE‐Active Free Radical Photogenerators and Enable High‐Performance Photodynamic Therapy under Hypoxia

Acceptor-donor-acceptor structured deep-red AIE photosensitizer: Lysosome-specific targeting, in vivo long-term imaging, and effective photodynamic therapy

An AIE Photosensitizer with Simultaneous Type I and Type II ROS Generation: Efficient Bacterial Elimination and Hypoxic Tumor Ablation

AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Building Block for Designing Bright Type I AIE‐Active Photosensitizers with Deep/Near‐infrared Red Fluorescence

Precise ligand engineering of Ir(III)-based photosensitizer with aggregation-induced emission for image-guided photodynamic therapy

Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction.

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Boost Highly Efficient Singlet Oxygen Generation and Accelerate Cancer Cell Apoptosis for Photodynamic Therapy by Logically Designed Mitochondria Targeted Near-Infrared AIEgens

Molecular Acceptor Engineering to Design Precisely NIR Type I Photosensitizer for Efficient PDT-based Synergistic Therapy